NitroMed NTMD

… placing our fair value estimate for NitroMed NTMD under review following Tuesday ..... decrease our fair value estimate. NitroMed will stop promoting BiDil, its ..... market has made it difficult for NitroMed to raise additional cash, which …

NitroMed NTMD should post another bad quarter next week, thanks to the poor progress of BiDil, its only approved drug. We're maintaining …

We're maintaining Nitromed 's NTMD fair value estimate following another ..... awareness. Despite these efforts, Nitromed can't seem to shake rampant generic ..... the hurdles ahead, we don't see Nitromed as a good bet even for those with …

Nitromed NTMD unveiled a study on March 26 that was intended, in part, to combat switching ..... a more reasonable sample size would more easily prove comparability. Nitromed shareholders have suffered because the Centers for Medicare and Medicaid …

… Americans. The drug's manufacturer, NitroMed NTMD , had previously given the NAACP ..... maintaining our fair value estimate for NitroMed until we see monthly sales improve ..... sure how much the letter will help NitroMed 's situation; the percentage …

Sales of NitroMed 's NTMD only drug, BiDil, are beginning to fall short of our already-modest ..... we'll probably reduce our fair value estimate. In mid-2006, NitroMed envisioned a hospital co-promotion agreement that would extend BiDil …

NitroMed NTMD fired 85% of its already reduced BiDil salesforce after failing ..... 1 per share as annual cost savings of $30 million increase NitroMed 's chances of success. NitroMed will continue to market BiDil through a much smaller team of …